Top Clinical Trials companies in India by Return on Capital Employed (ROCE)

This ranking features the top 74 Clinical Trials companies in India ranked by Return on Capital Employed (ROCE), averaging a Return on Capital Employed (ROCE) of 13.62%, for February 11, 2025.

India

Clinical Trials
Return on Capital Employed (ROCE)
#
Name
Return on Capital Employed (ROCE)
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
TAKE.NS

TAKE Solutions Limited

1

TAKE.NS
10,737.55%
March 31, 2024 USD 0.13 -0.49%

India
2
SANOFI.NS

Sanofi India Limited

2

SANOFI.NS
79.66%
Dec. 31, 2023 USD 61.92 -0.63%

India
3
INDSWFTLAB.NS

Ind-Swift Laboratories Limited

3

INDSWFTLAB.NS
66.72%
March 31, 2024 USD 1.12 -4.46%

India
4
WANBURY.NS

Wanbury Limited

4

WANBURY.NS
66.09%
March 31, 2024 USD 2.63 -4.64%

India
5
PGHL.NS

Procter & Gamble Health Limited

5

PGHL.NS
48.66%
June 30, 2024 USD 60.92 -1.55%

India
6
ABBOTINDIA.NS

Abbott India Limited

6

ABBOTINDIA.NS
42.24%
March 31, 2024 USD 339.25 -0.02%

India
7
GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited

7

GLAXO.NS
40.25%
March 31, 2024 USD 24.47 -2.67%

India
8
ASTRAZEN.NS

AstraZeneca Pharma India Limited

8

ASTRAZEN.NS
30.62%
March 31, 2024 USD 86.25 -0.49%

India
9
NEULANDLAB.NS

Neuland Laboratories Limited

9

NEULANDLAB.NS
29.55%
March 31, 2024 USD 167.70 3.37%

India
10
NATCOPHARM.NS

NATCO Pharma Limited

10

NATCOPHARM.NS
28.53%
March 31, 2024 USD 14.65 -2.48%

India
11
TORNTPHARM.NS

Torrent Pharmaceuticals Limited

11

TORNTPHARM.NS
28.08%
March 31, 2024 USD 36.49 -1.65%

India
12
CONCORDBIO.NS

Concord Biotech Limited

12

CONCORDBIO.NS
26.46%
March 31, 2024 USD 25.55 -4.35%

India
13
JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

13

JBCHEPHARM.NS
25.44%
March 31, 2024 USD 19.18 0.81%

India
14
DRREDDY.NS

Dr. Reddy's Laboratories Limited

14

DRREDDY.NS
25.19%
March 31, 2024 USD 13.95 -1.21%

India
15
MANKIND.NS

Mankind Pharma Limited

15

MANKIND.NS
24.50%
March 31, 2024 USD 28.60 -0.29%

India
16
INDSWFTLTD.NS

Ind-Swift Limited

16

INDSWFTLTD.NS
23.76%
March 31, 2024 USD 0.17 -3.99%

India
17
INDGN.NS

Indegene Limited

17

INDGN.NS
22.47%
March 31, 2024 USD 7.07 -1.30%

India
18
CIPLA.NS

Cipla Limited

18

CIPLA.NS
21.03%
March 31, 2024 USD 16.67 -0.55%

India
19
NGLFINE.NS

NGL Fine-Chem Limited

19

NGLFINE.NS
20.91%
March 31, 2024 USD 17.25 -19.71%

India
20
PFIZER.NS

Pfizer Limited

20

PFIZER.NS
20.55%
March 31, 2024 USD 48.55 -2.16%

India
21
ZYDUSLIFE.NS

Zydus Lifesciences Limited

21

ZYDUSLIFE.NS
20.29%
March 31, 2024 USD 11.02 -2.61%

India
22
SUPRIYA.NS

Supriya Lifescience Limited

22

SUPRIYA.NS
19.87%
March 31, 2024 USD 8.27 -6.12%

India
23
SUVENPHAR.NS

Suven Pharmaceuticals Limited

23

SUVENPHAR.NS
19.24%
March 31, 2024 USD 12.77 -3.16%

India
24
MARKSANS.NS

Marksans Pharma Limited

24

MARKSANS.NS
18.97%
March 31, 2024 USD 3.05 -1.72%

India
25
BALPHARMA.NS

Bal Pharma Limited

25

BALPHARMA.NS
18.85%
March 31, 2024 USD 1.20 -5.08%

India
26
MEDICO.NS

Medico Remedies Limited

26

MEDICO.NS
18.79%
March 31, 2024 USD 0.79 -11.26%

India
27
FDC.NS

FDC Limited

27

FDC.NS
18.55%
March 31, 2024 USD 5.26 -2.10%

India
28
THYROCARE.NS

Thyrocare Technologies Limited

28

THYROCARE.NS
18.27%
March 31, 2024 USD 8.89 -0.43%

India
29
GUFICBIO.NS

Gufic Biosciences Limited

29

GUFICBIO.NS
18.19%
March 31, 2024 USD 4.72 -1.03%

India
30
GRANULES.NS

Granules India Limited

30

GRANULES.NS
18.00%
March 31, 2024 USD 6.50 -2.02%

India
31
LUPIN.NS

Lupin Limited

31

LUPIN.NS
17.43%
March 31, 2024 USD 24.79 -1.08%

India
32
AARTIDRUGS.NS

Aarti Drugs Limited

32

AARTIDRUGS.NS
16.44%
March 31, 2024 USD 4.63 -2.34%

India
33
VIMTALABS.NS

Vimta Labs Limited

33

VIMTALABS.NS
16.31%
March 31, 2024 USD 12.17 3.64%

India
34
JAGSNPHARM.NS

Jagsonpal Pharmaceuticals Limited

34

JAGSNPHARM.NS
15.50%
March 31, 2024 USD 2.77 -8.82%

India
35
METROPOLIS.NS

Metropolis Healthcare Limited

35

METROPOLIS.NS
15.47%
March 31, 2024 USD 20.54 -1.93%

India
36
THEMISMED.NS

Themis Medicare Limited

36

THEMISMED.NS
14.83%
March 31, 2024 USD 2.52 -4.77%

India
37
KILITCH.NS

Kilitch Drugs (India) Limited

37

KILITCH.NS
14.38%
March 31, 2024 USD 3.67 -1.37%

India
38
INNOVACAP.NS

Innova Captab Limited

38

INNOVACAP.NS
14.30%
March 31, 2024 USD 10.29 -2.30%

India
39
AUROPHARMA.NS

Aurobindo Pharma Limited

39

AUROPHARMA.NS
14.26%
March 31, 2024 USD 13.45 -0.86%

India
40
KOPRAN.NS

Kopran Limited

40

KOPRAN.NS
14.09%
March 31, 2024 USD 2.04 -1.99%

India
41
APLLTD.NS

Alembic Pharmaceuticals Limited

41

APLLTD.NS
13.81%
March 31, 2024 USD 10.15 0.53%

India
42
SYNGENE.NS

Syngene International Limited

42

SYNGENE.NS
13.16%
March 31, 2024 USD 8.42 -0.78%

India
43
SYNCOMF.NS

Syncom Formulations (India) Limited

43

SYNCOMF.NS
12.85%
March 31, 2024 USD 0.21 -1.97%

India
44
SMSPHARMA.NS

SMS Pharmaceuticals Limited

44

SMSPHARMA.NS
12.63%
March 31, 2024 USD 2.41 -2.63%

India
45
GLAND.NS

Gland Pharma Limited

45

GLAND.NS
12.51%
March 31, 2024 USD 16.89 -2.20%

India
46
IOLCP.NS

IOL Chemicals and Pharmaceuticals Limited

46

IOLCP.NS
11.74%
March 31, 2024 USD 4.33 -0.95%

India
47
BLISSGVS.NS

Bliss GVS Pharma Limited

47

BLISSGVS.NS
11.62%
March 31, 2024 USD 1.71 0.29%

India
48
ERIS.NS

Eris Lifesciences Limited

48

ERIS.NS
11.43%
March 31, 2024 USD 16.07 -4.58%

India
49
IPCALAB.NS

Ipca Laboratories Limited

49

IPCALAB.NS
11.12%
March 31, 2024 USD 16.55 -3.58%

India
50
ZIMLAB.NS

ZIM Laboratories Limited

50

ZIMLAB.NS
10.53%
March 31, 2024 USD 1.19 -2.10%

India
Frequently Asked Questions
  • Which Clinical Trials company in India has the highest Return on Capital Employed (ROCE) ?

    The Clinical Trials company in India with the highest Return on Capital Employed (ROCE) is TAKE Solutions Limited (NSE: TAKE.NS) at 10,737.55%.

  • Which Clinical Trials company in India has the lowest Return on Capital Employed (ROCE) ?

    The Clinical Trials company in India with the lowest Return on Capital Employed (ROCE) is Sun Pharma Advanced Research Company Limited (NSE: SPARC.NS) at -154.27%.

SV Wall Street